Tomoyuki Hamamoto

1.1k total citations · 1 hit paper
26 papers, 917 citations indexed

About

Tomoyuki Hamamoto is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Tomoyuki Hamamoto has authored 26 papers receiving a total of 917 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Genetics and 4 papers in Oncology. Recurrent topics in Tomoyuki Hamamoto's work include Virus-based gene therapy research (8 papers), RNA Interference and Gene Delivery (7 papers) and Cancer-related Molecular Pathways (4 papers). Tomoyuki Hamamoto is often cited by papers focused on Virus-based gene therapy research (8 papers), RNA Interference and Gene Delivery (7 papers) and Cancer-related Molecular Pathways (4 papers). Tomoyuki Hamamoto collaborates with scholars based in Japan and Myanmar. Tomoyuki Hamamoto's co-authors include Fumio Ohseto, Munetaka Ishiyama, Masami Watanabe, Keiji Suzuki, Kazumi Sasamoto, Hideyuki Tominaga, Hitoshi Sasaki, Tomoaki Kurosaki, Takashi Kitahara and Hiroo Nakagawa and has published in prestigious journals such as Journal of Controlled Release, Annals of the New York Academy of Sciences and International Journal of Pharmaceutics.

In The Last Decade

Tomoyuki Hamamoto

24 papers receiving 891 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A water-soluble tetrazolium salt useful for colorimetric cell viability assay

1999 579 citations Tomoyuki Hamamoto, Masami Watanabe et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tomoyuki Hamamoto Japan	13	442	131	100	93	91	26	917
Brooke J. Marfell Australia	10	573 1.3×	137 1.0×	44 0.4×	66 0.7×	95 1.0×	10	1.2k
Annie Joubert South Africa	18	512 1.2×	92 0.7×	132 1.3×	79 0.8×	184 2.0×	44	1.1k
Wenjie Wang China	19	525 1.2×	219 1.7×	65 0.7×	221 2.4×	93 1.0×	87	1.3k
Richard A Moravec United States	13	659 1.5×	205 1.6×	62 0.6×	63 0.7×	129 1.4×	21	1.5k
Zdzisław Krawczyk Poland	23	840 1.9×	103 0.8×	134 1.3×	39 0.4×	83 0.9×	54	1.3k
Sourav Bhattacharya India	18	504 1.1×	95 0.7×	79 0.8×	76 0.8×	90 1.0×	38	1.4k
Debasish Bhattacharyya India	22	472 1.1×	111 0.8×	193 1.9×	94 1.0×	54 0.6×	70	1.2k
Zhen Qi China	16	268 0.6×	105 0.8×	69 0.7×	66 0.7×	97 1.1×	42	762
Sheila Maria Brochado Winnischofer Brazil	20	462 1.0×	137 1.0×	42 0.4×	93 1.0×	111 1.2×	50	1.2k
Priti Kumar	9	680 1.5×	212 1.6×	103 1.0×	127 1.4×	127 1.4×	19	1.6k

Countries citing papers authored by Tomoyuki Hamamoto

Since Specialization

Citations

This map shows the geographic impact of Tomoyuki Hamamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoyuki Hamamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoyuki Hamamoto more than expected).

Fields of papers citing papers by Tomoyuki Hamamoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoyuki Hamamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoyuki Hamamoto. The network helps show where Tomoyuki Hamamoto may publish in the future.

Co-authorship network of co-authors of Tomoyuki Hamamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoyuki Hamamoto. A scholar is included among the top collaborators of Tomoyuki Hamamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoyuki Hamamoto. Tomoyuki Hamamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hamamoto, Tomoyuki, et al.. (2022). Evaluation of Safety Management System for Pharmacotherapy Based on the Unified Management System for Side Effects and Allergy Information. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 48(5). 203–211.

Takada, Kimihiko, et al.. (2020). Bcl-2/Bcl-xL inhibitor navitoclax increases the antitumor effect of Chk1 inhibitor prexasertib by inducing apoptosis in pancreatic cancer cells via inhibition of Bcl-xL but not Bcl-2. Molecular and Cellular Biochemistry. 472(1-2). 187–198. 13 indexed citations

Takada, Kimihiko, et al.. (2019). Prexasertib increases the sensitivity of pancreatic cancer cells to gemcitabine and S‑1. Oncology Reports. 43(2). 689–699. 12 indexed citations

Kose, Eiji, et al.. (2018). Anticholinergic load negatively correlates with recovery of cognitive activities of daily living for geriatric patients after stroke in the convalescent stage. Journal of Clinical Pharmacy and Therapeutics. 43(6). 799–806. 15 indexed citations

Hamamoto, Tomoyuki, et al.. (2014). Visualization and Analysis of Adverse Reactions of Molecularly Targeted Anticancer Agents Using the Self-organizing Map (SOM). YAKUGAKU ZASSHI. 134(10). 1069–1080. 2 indexed citations

Kurosaki, Tomoaki, Yukinobu Kodama, Hiroo Nakagawa, et al.. (2011). Nanoparticles Electrostatically Coated with Folic Acid for Effective Gene Therapy. Molecular Pharmaceutics. 8(3). 913–919. 44 indexed citations

Kitahara, Takashi, Hiroo Nakagawa, Yukinobu Kodama, et al.. (2009). Comparison of Tacrolimus Blood Level Monitoring Measurements Made by Different Instruments. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 35(7). 453–457. 1 indexed citations

Kurosaki, Tomoaki, Takashi Kitahara, Shigeru Kawakami, et al.. (2009). γ-Polyglutamic acid-coated vectors for effective and safe gene therapy. Journal of Controlled Release. 142(3). 404–410. 84 indexed citations

Kurosaki, Tomoaki, Takashi Kitahara, Mugen Teshima, et al.. (2009). Exploitation of De Novo Helper-Lipids for Effective Gene Delivery.. Journal of Pharmacy & Pharmaceutical Sciences. 11(4). 56–56. 14 indexed citations

10.

Kurosaki, Tomoaki, Megumi Matsumoto, Yukinobu Kodama, et al.. (2009). Pulmonary gene delivery of hybrid vector, lipopolyplex containing N-lauroylsarcosine, via the systemic route. Journal of Controlled Release. 136(3). 213–219. 14 indexed citations

11.

Hamamoto, Tomoyuki, Keiji Suzuki, Motohiro Yamauchi, et al.. (2008). p53 status-dependent sensitization of human tumour cells to hyperthermia by plant flavonol. International Journal of Hyperthermia. 24(5). 415–424. 1 indexed citations

12.

Matsumoto, Megumi, Tomoaki Kurosaki, Hiroo Nakagawa, et al.. (2008). Hybrid vector including polyethylenimine and cationic lipid, DOTMA, for gene delivery. International Journal of Pharmaceutics. 363(1-2). 58–65. 22 indexed citations

13.

Futagami, Seiji, Kenji Suzuki, Tetsuro Hiratsuka, et al.. (2007). Chemopreventive effect of celecoxib in gastric cancer. Inflammopharmacology. 15(1). 1–4. 24 indexed citations

14.

Hamamoto, Tomoyuki, Keiji Suzuki, Shuji Kodama, et al.. (2007). Correlation of malignant phenotypes of human tumour cell lines with augmented expression of Hsp72 protein measured by laser scanning cytometry. International Journal of Hyperthermia. 23(4). 363–370. 4 indexed citations

15.

Higuchi, Norihide, Tomoyuki Hamamoto, Takashi Kitahara, et al.. (2005). Investigation of Cause of Contamination of Aseptic Total Parenteral Nutrition (TPN) Admixtures. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 31(3). 211–216. 1 indexed citations

16.

Hamamoto, Tomoyuki, Keiji Suzuki, Hitoshi Sasaki, et al.. (2005). Differences in Effects of Oncogenes on Sensitivity to Anticancer Drugs. Journal of Radiation Research. 46(2). 197–203. 5 indexed citations

17.

Makiyama, Kazuya, Fuminao Takeshima, & Tomoyuki Hamamoto. (2005). Efficacy of Rebamipide Enemas in Active Distal Ulcerative Colitis and Proctitis: A Prospective Study Report. Digestive Diseases and Sciences. 50(12). 2323–2329. 22 indexed citations

18.

Kitahara, Kenji, Wataru Yasui, Hiroshi Yokozaki, et al.. (1996). Expression of cyclin D1, CDK4 and p27KIP1 is associated with the p16MTS1 gene status in human esophageal carcinoma cell lines.. PubMed. 1(1). 7–12. 19 indexed citations

19.

Mori, Yo, Tomoyuki Hamamoto, & Susumu Otomo. (1991). Sulfation of Minoxidil in Keratinocytes and Hair Follicles and the Stimulatory Effect of Minoxidil on the Biosynthesis of Glycosaminoglycans. Annals of the New York Academy of Sciences. 642(1). 473–475. 5 indexed citations

20.

Hamamoto, Tomoyuki & Yo Mori. (1989). Sulfation of minoxidil in keratinocytes and hair follicles.. PubMed. 66(1). 33–44. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact